This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Tech Stocks Apr 22 Earnings Roster: APH, LRCX, NTGR & More
by Aniruddha Ganguly
Here we take a sneak peek at the earnings releases of tech stocks scheduled to report on Apr 22.
Should You Buy Plexus (PLXS) Ahead of Earnings?
by Zacks Equity Research
Plexus (PLXS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Analysts Estimate Plexus (PLXS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Plexus (PLXS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Plexus (PLXS) Q1 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Plexus' (PLXS) first-quarter results reflect robust revenues from Healthcare/Life Sciences, Industrial/Commercial and Aerospace/Defense sectors.
Plexus (PLXS) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 7.53% and 6.36%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Fourth Quarter Earnings Reports in Week Ahead
by Zacks Equity Research
Fourth Quarter Earnings Reports in Week Ahead
On MLK Day, a Busy Week Expected
by Mark Vickery
Q4 earnings season, the World Economic Forum in Davos and President Trump's impeachment trial all get underway beginning tomorrow.
Plexus (PLXS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Tech Stocks Likely to Maintain Solid Momentum in 2020
by Shalu Saraf
Here we pick five technology stocks that are likely to maintain their solid momentum in 2020.
The Zacks Analyst Blog Highlights: Amkor, Plexus, CACI, CDW and NIC
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amkor, Plexus, CACI, CDW and NIC
Electronics to Maintain Solid Momentum in 2020: 5 Stocks to Buy
by Shilpa Mete
Here we recommend five electronics stocks that are well-poised to sustain momentum in 2020 owing to growing proliferation of electronics across every major sector.
5 Top Notch Technology Stocks Set to Beat Nasdaq in 2020
by Shalu Saraf
Here we pick five technology stocks that are set to outperform Nasdaq in 2020.
Jabil (JBL) Looks Good: Stock Adds 6.9% in Session
by Zacks Equity Research
Jabil (JBL) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
5 Technology Stocks That Have Crushed Nasdaq in 2019
by Radhika Pujara
Here we pick five technology stocks that have outperformed Nasdaq in 2019.
6 Tech Stocks That Have Crushed FAANG in 2019
by Aniruddha Ganguly
Here we pick six stocks that have outperformed the FAANG group on a year-to-date basis in 2019.
The Zacks Analyst Blog Highlights: Ultra Clean Holdings, Plexus, Tennant, Cohu and Kaman
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Ultra Clean Holdings, Plexus, Tennant, Cohu and Kaman
5 Top-Ranked Manufacturing Stocks to Buy Amid Slowdown in 2019
by Nalak Das
Despite slowdown, a few manufacturing stocks popped in the past six months and still have upside left.
Plexus (PLXS) Up 7.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus
5 Top Momentum Stocks in October That Still Have Upside Left
by Nalak Das
Possibility of at least an interim trade deal between the largest trading countries of the world boosted investors' confidence on risky assets like equities.
Plexus Corp. (PLXS) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Plexus Corp. (PLXS).
Zacks.com featured highlights include: Plexus, Costamare, United Therapeutics, Intel and First American Financial
by Zacks Equity Research
Zacks.com featured highlights include: Plexus, Costamare, United Therapeutics, Intel and First American Financial
Top Ranked Momentum Stocks to Buy for October 30th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 30th
5 Solid Relative Price Strength Stocks to Make You Rich
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.